While ipamorelin shares similarities with GHRP-2 and GHRP-6 by stimulating GH release through GHSR-1a receptors, it distinguishes itself with a safer profile and minimized side effects. Clinical studies show that ipamorelin does not produce the same side effects on organ sizes or joint discomfort often linked to GH treatments, making it an appealing choice for patients seeking anabolic benefits with lower risk. The ability to stimulate GH and IGF-1 naturally and selectively makes ipamorelin an advanced, safer option compared to traditional GH therapies.
Sinha, D.K., Balasubramanian, A., Tatem, A.J., Rivera-Mirabal, J., Yu, J., Kovac, J., Pastuszak, A.W. and Lipshultz, L.I., 2020. Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males. Translational Andrology and Urology.
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For detailed information about Ipamorelin by Driada Medical, consult with your doctor or healthcare professional.
Sinha, D.K., Balasubramanian, A., Tatem, A.J., Rivera-Mirabal, J., Yu, J., Kovac, J., Pastuszak, A.W. and Lipshultz, L.I., 2020. Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males. Translational Andrology and Urology.
Sinha, D.K., Balasubramanian, A., Tatem, A.J., Rivera-Mirabal, J., Yu, J., Kovac, J., Pastuszak, A.W. and Lipshultz, L.I., 2020. Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males. Translational Andrology and Urology.
Sinha, D.K., Balasubramanian, A., Tatem, A.J., Rivera-Mirabal, J., Yu, J., Kovac, J., Pastuszak, A.W. and Lipshultz, L.I., 2020. Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males. Translational Andrology and Urology.